Study Title: A Multicenter, Open Label, Randomized, Phase 2 Study of Venetoclax and Azacitidine Plus Cusatuzumab Versus Venetoclax and Azacitidine Alone in Newly Diagnosed AML Patients who are not Candidates for Intensive Therapy
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Coltoff, Alexander, at coltoff@musc.edu.Study Coordinator, Baker, Hana, at bakerhan@musc.edu.Trial opened at the following institutions: Medical University of South Carolina